Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...

TD Cowen analyst Doug Creutz says Roblox (RBLX) saw a strong finish to the year following a “Dress to Impress” update in mid-December and ...

TD Cowen analyst Brendan Smith raised the firm’s price target on Ginkgo Bioworks (DNA) to $16 from $10 and keeps a Buy rating on the shares.

Fintel reports that on January 5, 2025, TD COWEN upgraded their outlook for Bank of Nova Scotia (NYSE:BNS) from Hold to Buy. Analyst Price Forecast Suggests 9.31% Upside As of December 24 ...

Investing.com-- TD Cowen analysts have upgraded Salesforce Inc's (NYSE:CRM) rating and raised their price target, citing optimism over the company’s role in the expanding "Agentic AI" cycle.

TD Cowen upgraded Salesforce's (NYSE:CRM) rating to Buy from Hold and raised the price target to $400 from $380. Shares of Salesforce rose about 2% on Friday. Analysts led by Derrick Wood said ...

The rise in targets in recent days, however, pushes the stock toward $360 after UBS Group raised its target on Salesforce and maintained a "neutral" rating, and Needham & Company raised the price ...

Investing.com-- TD Cowen analysts have increased their price target for Butterfly Network, Inc (NYSE:BFLY), citing robust momentum in the global rollout of its iQ3 handheld ultrasound device.

A U.S. watchdog is suing Capital One for allegedly misleading consumers about its offerings for high-interest savings ...

Lamar Advertising (NASDAQ:LAMR – Get Free Report) has earned an average recommendation of “Hold” from the five brokerages that are covering the stock, Marketbeat reports. Four investment analysts have ...

Try refreshing your browser, or tap here to see other videos from our team. Cowan, a point-scoring machine for the London Knights who hopes to carry that reputation into the National Hockey League ...